Peptides Inhibit Vascular Permeability via PAK-PIX-GIT-MEK Complex Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments lack effective methods to regulate vascular permeability, which contributes to tissue injury and inflammation in conditions like acute lung injury, stroke, and myocardial infarction, with no specific treatment available for acute lung injury.
Innovation Solution
Development of peptides that compete with or regulate the PAK-PIX-GIT-MEK complex to disrupt vascular permeability by blocking interactions at specific sites, using sequences such as PPPVIAPRPEHTKSVYTR and AALEEDAQILKVI, which inhibit protein complex formation or interaction, thereby reducing vascular leak.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If vascular permeability is increased to facilitate immune response and wound healing, then immune cell passage and tissue repair are improved, but tissue injury and inflammation are worsened
Solution Approach 1:
The invention uses small molecule compounds to modulate the activity of Rac GTPase and its downstream effectors, changing the physiological parameter of vascular permeability from a binary state to a controllable spectrum. By inhibiting Rac activation or downstream PAK/MLCK pathways, the compounds reduce excessive vascular leakage while preserving baseline permeability needed for immune function.
Solution Approach 2:
The invention introduces small molecule compounds as intermediary substances that mediate between the immune system's need for vascular permeability and the tissue's need to prevent excessive leakage. These compounds selectively bind to Rac GTPase or its effectors, acting as molecular mediators that fine-tune the balance between beneficial immune cell infiltration and harmful edema formation.
2Device complexity
If no specific treatment is available for acute lung injury, then current medical care maintains simplicity, but patient mortality remains high at 30-40%
Solution Approach 1:
The invention extracts and targets the specific molecular mechanism (Rac GTPase signaling pathway) that drives vascular permeability in acute lung injury. By isolating this key pathological pathway from the complex cascade of inflammatory events, the invention enables selective intervention with small molecule inhibitors, providing a targeted treatment that addresses the root cause of lung injury without requiring complex multi-modal therapy protocols.
3Adaptability or versatility
If VEGF is secreted by hypoxic tissues to promote angiogenesis, then blood vessel formation is improved, but vascular leak and tissue damage are worsened in stroke and myocardial infarction
Solution Approach 1:
The invention introduces dynamic control of vascular permeability through reversible small molecule inhibition of Rac GTPase. Unlike permanent structural modifications, the compounds allow the vascular endothelium to dynamically adjust its permeability state - remaining permeable during angiogenesis when needed, but becoming less permeable when excessive leakage occurs. This temporal and spatial dynamic regulation preserves angiogenic benefits while minimizing harmful vascular leak.
Data Source
AI summary
The present invention relates to methods and compositions for regulating vascular permeability. The present invention relates to methods and compositions for blocking proteins and signal transduction pathways involved in increasing vascular permeability.